1.
Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice
by Jiang, Xian
Cancer Science, November 2009, Vol.100(11), pp.2226-2233
2.
Role of the Spleen in Cyclophosphamide-induced Hematosuppression and Extramedullary Hematopoiesis in Mice
by Wang, Yuli
Archives of Medical Research, 2009, Vol.40(4), pp.249-255
3.
Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo
by Wei, Zheng
Tumor Biology, 2013, Vol.34(1), pp.181-192
4.
Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice
by Liu, Bing
Cancer Science, July 2006, Vol.97(7), pp.675-681
5.
2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma
by Lin, Han
Tumor Biology, 2016, Vol.37(1), pp.381-391
6.
ABT-737 synergizes with arsenic trioxide to induce apoptosis of gastric carcinoma cells in vitro and in vivo.
by Sun, X P
The Journal of international medical research, 2012, Vol.40(4), pp.1251-1264
7.
An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells
by Tang, Shuyao
Oncotarget, 08 November 2016, Vol.7(45), pp.73257-73269
8.
Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer
by Zou Xiaolong
Journal of Biomedical Science, 01 December 2008, Vol.16(1), p.33
9.
Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy
by Ma, Lixin
Journal of Hepatology, 2007, Vol.46(1), pp.98-106
Filter electronic articles 9 Hits
Remove Filters
